May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Is There an Association of Topical Ocular Hypotensive Medication With Lens Opacification And Visual Function?: Evidence From the Ocular Hypertension Treatment Study (OHTS)
Author Affiliations & Notes
  • M. Kass
    Ophthalmology, Washington University, St. Louis, MO
  • J. Beiser
    Ophthalmology, Washington University, St. Louis, MO
  • D. Herman
    Ophthalmology, Mayo Foundation, Rochester, MN
  • K. Lamping
    Ophthalmology, University Suburban Health Center, South Euclid, OH
  • J. Soltau
    Ophthalmology, University of Louisville, Louisville, KY
  • M. Gordon
    Ophthalmology, Washington University, St. Louis, MO
  • Footnotes
    Commercial Relationships  M. Kass, Pfizer F; J. Beiser, None; D. Herman, None; K. Lamping, None; J. Soltau, None; M. Gordon, None.
  • Footnotes
    Support  NIH Grant EY09307, EY09341
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2448. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Kass, J. Beiser, D. Herman, K. Lamping, J. Soltau, M. Gordon; Is There an Association of Topical Ocular Hypotensive Medication With Lens Opacification And Visual Function?: Evidence From the Ocular Hypertension Treatment Study (OHTS) . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2448.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Abstract:
 

To determine if topical ocular hypotensive medication is associated with lens opacification and/or decreased visual function. We compared participants in the observation group to those the medication group using the last data prior to June, 2002 for: a. cataract surgery or combined cataract/filtering surgery, b. best corrected ETDRS visual acuity, c. mean deviation and foveal threshold from Humphrey visual fields. After June 2002, topical medication was offered to participants in the observation group. Masked LOCS III gradings were conducted between March 2003 and October 2004.

 

 

 

In OHTS, little evidence was found to support the hypothesis that topical ocular hypotensive medication is associated with lens opacification or decreased visual function.

 

 
Keywords: cataract • visual acuity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×